{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:58:09Z","timestamp":1790913489112,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["21767"],"award-info":[{"award-number":["21767"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101338","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:46:16Z","timestamp":1785487576000},"page":"101338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Altered expression of ET-1 and HMGB1 together with higher MMP-9 activity in serum-derived exosomes of chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"48","author":[{"given":"Maryam","family":"Ghotbbahaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Amoei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-4520","authenticated-orcid":false,"given":"Mohsen","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Taghiloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Zaboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Eslami-Jouybari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Mirzakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Shekarriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctarc.2026.101338_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090244","article-title":"Role of chronic lymphocytic leukemia (CLL)-derived exosomes in tumor progression and survival","volume":"13","author":"Nistic\u00f2","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101338_bib0002","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101338_bib0003","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","article-title":"Chronic lymphocytic leukaemia: from genetics to treatment","volume":"16","author":"Bosch","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101338_bib0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11899-023-00700-z","article-title":"Relapsed\/refractory chronic lymphocytic leukemia (CLL)","volume":"18","author":"Odetola","year":"2023","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101338_bib0005","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s11864-023-01129-5","article-title":"Current approaches of immune checkpoint therapy in chronic lymphocytic leukemia","volume":"24","author":"Taghiloo","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101338_bib0006","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3390\/cancers15082307","article-title":"Extracellular vesicles in chronic lymphocytic leukemia: tumor microenvironment messengers as a basis for new targeted therapies?","volume":"15","author":"Dubois","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101338_bib0007","doi-asserted-by":"crossref","DOI":"10.31083\/FBL44663","article-title":"Deciphering the role of KIF18A in Osteosarcoma progression: an integrative analysis and experimental validation","volume":"30","author":"Gu","year":"2025","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ctarc.2026.101338_bib0008","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3389\/fonc.2020.01422","article-title":"Importance of crosstalk between chronic lymphocytic leukemia cells and the stromal microenvironment: direct contact, soluble factors, and extracellular vesicles","volume":"10","author":"Dubois","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0009","doi-asserted-by":"crossref","DOI":"10.1515\/med-2024-0995","article-title":"Sox9: a potential regulator of cancer stem cells in osteosarcoma","volume":"19","author":"Li","year":"2024","journal-title":"Open Med."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101338_bib0010","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.62347\/KTYO7957","article-title":"Relationship between ki-67 and P53 immunohistochemical expression and osteosarcoma chemotherapy sensitivity and long-term prognosis","volume":"17","author":"Gu","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101338_bib0011","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3324\/haematol.2020.268037","article-title":"Targeting the tumor microenvironment in chronic lymphocytic leukemia","volume":"106","author":"Svanberg","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2127507","article-title":"Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo","volume":"11","author":"Gargiulo","year":"2022","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101338_bib0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cells10020217","article-title":"Nurse-like cells and chronic lymphocytic leukemia B cells: a mutualistic crosstalk inside tissue microenvironments","volume":"10","author":"Fiorcari","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101338_bib0014","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/07357907.2010.494319","article-title":"Expression profile of galectin-1 and galectin-3 molecules in different subtypes of chronic lymphocytic leukemia","volume":"28","author":"Asgarian-Omran","year":"2010","journal-title":"Cancer Invest."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101338_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098818","article-title":"Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor","volume":"9","author":"Maffei","year":"2014","journal-title":"PloS one"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101338_bib0016","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood-2013-10-529610","article-title":"Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia","volume":"123","author":"Jia","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101338_bib0017","article-title":"Clinical significance of MMP-9 overexpression in endometrial cancer: a PRISMA-compliant meta-analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101338_bib0018","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.3390\/cancers14153776","article-title":"Exosomes from EGFR-mutated adenocarcinoma induce a hybrid EMT and MMP9-dependant tumor invasion","volume":"14","author":"Jouida","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101338_bib0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","article-title":"Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer","volume":"54","author":"Li","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0021","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41389-022-00431-5","article-title":"Exosomes and cancer - diagnostic and prognostic biomarkers and therapeutic vehicle","volume":"11","author":"Wang","year":"2022","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101338_bib0022","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3892\/etm.2023.11825","article-title":"Tumour\u2011derived exosomes and their emerging roles in leukaemia (Review)","volume":"25","author":"Chen","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101338_bib0023","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41375-024-02188-9","article-title":"Leukemogenesis occurs in a microenvironment enriched by extracellular microvesicles\/exosomes: recent discoveries and questions to be answered","volume":"38","author":"Ratajczak","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal.: CCS"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101338_bib0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.clinthera.2014.05.010","article-title":"Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells","volume":"36","author":"Oksvold","year":"2014","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ejh.14224","article-title":"Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: an update review","volume":"113","author":"Taghiloo","year":"2024","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101338_bib0027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12026-020-09146-4","article-title":"Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8(+) T cells in early clinical stages of chronic lymphocytic leukemia","volume":"68","author":"Rezazadeh","year":"2020","journal-title":"Immunol. Res."},{"issue":"6478","key":"10.1016\/j.ctarc.2026.101338_bib0028","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Sci"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101338_bib0029","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: biological implications and therapeutic opportunities","volume":"13","author":"Rosan\u00f2","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101338_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2016.12.006","article-title":"The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli","volume":"54","author":"Martinelli","year":"2017","journal-title":"Leuk Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101338_bib0031","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5152\/eurasianjmed.2020.20033","article-title":"Role of Endothelin 1 on proliferation and migration of Human MCF-7 cells","volume":"52","author":"Cinar","year":"2020","journal-title":"Eurasian J. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101338_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1384109","article-title":"Multiple functions of HMGB1 in cancer","volume":"14","author":"Lv","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101338_bib0034","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-018-0898-6","article-title":"Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101338_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41389-019-0126-2","article-title":"Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1(+) TAM expansion","volume":"8","author":"Li","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ctarc.2026.101338_bib0036","doi-asserted-by":"crossref","unstructured":"Palacios F, Blanco G, Vanarsa K, Dugyala P, Allen SL, Kieso Y, et al. Serum proteomic analyses suggest that the HMGB1 and other inflammatory pathways are operational in MBL and are less in overt CLL. 2021;138:2625.","DOI":"10.1182\/blood-2021-152514"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101338_bib0037","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/cancers14071847","article-title":"MMP9: a tough target for targeted therapy for cancer","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101338_bib0038","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694325","article-title":"Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia","volume":"39","author":"Gusella","year":"2017","journal-title":"Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101338_bib0039","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"Pegtel","year":"2019","journal-title":"Exosomes. Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101338_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles."},{"key":"10.1016\/j.ctarc.2026.101338_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8545347","article-title":"Isolation of extracellular vesicles: general methodologies and latest trends","volume":"2018","author":"Konoshenko","year":"2018","journal-title":"Biomed. Res. Int."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:49:26Z","timestamp":1790912966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":41,"alternative-id":["S2468294226002492"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101338","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression of ET-1 and HMGB1 together with higher MMP-9 activity in serum-derived exosomes of chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101338"}}